← Back to Search

Deep Brain Stimulation

Boston Scientific Vercise PC IPG with directional DBS lead for Parkinson's Disease

N/A
Waitlist Available
Led By Harrison C Walker, MD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Enrollment in "Biomarkers to Guide Directional DBS for Parkinson's Disease" (ClinicalTrials.gov Identifier: NCT03353688)
Diagnosis of Parkinson's disease with and without dystonia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes
Awards & highlights

Study Summary

This trial is testing if a new rating scale can help assess the severity of dystonia in Parkinson's disease patients.

Eligible Conditions
  • Parkinson's Disease
  • Dystonia Parkinsonism

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dystonia

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dystonia Severity AssessmentExperimental Treatment1 Intervention
We will measure the effects of DBS on dystonia by assessing changes in the Burke-Fahn-Marsden Dystonia Rating Scale at 2, 4, 6, and 12 months after surgery to implant the Boston Scientific Vercise PC IPG with directional DBS lead versus preoperative baseline.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Boston Scientific Vercise PC IPG with directional DBS lead
2018
N/A
~40

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,569 Previous Clinical Trials
2,268,853 Total Patients Enrolled
Michael J. Fox Foundation for Parkinson's ResearchOTHER
112 Previous Clinical Trials
535,118 Total Patients Enrolled
Harrison C Walker, MDPrincipal InvestigatorAssociate Professor of Neurology
1 Previous Clinical Trials
175 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Mar 2025